Literature DB >> 8807141

The treatment of hypertension.

J Chalmers1.   

Abstract

1. A 'retrospective' of the development of the drug treatment of hypertension is presented from the early days of ganglion blockers to the present time together with a review of the evidence of benefit from treatment. 2. Current issues and debates are summarised including shortfalls in the control of hypertension in populations, difficulties surrounding the measurement of blood pressure, disagreement on the levels of blood pressure to treat, the goal blood pressures to aim at, issues surrounding lifestyle measures such as the low salt diet and low intensity exercise, and treatment with diuretics and with calcium antagonists. 3. A 'perspective' is presented on some avenues for progress in the years ahead. These will include the identification of genetic markers to determine the hypertensive individuals with the greatest risk of death and of cardiovascular complications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807141      PMCID: PMC2042636          DOI: 10.1046/j.1365-2125.1996.03686.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  2 in total

1.  Cyclosporin enhances the tendency towards oedema and flushing noted on dihydropyridine calcium channel blockers.

Authors:  R O von Vigier; E Fossali; A Edefonti; B Vogt; M G Bianchetti
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

Review 2.  Exercise and hypertension: facts and uncertainties.

Authors:  M A van Baak
Journal:  Br J Sports Med       Date:  1998-03       Impact factor: 13.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.